Use of dihydromyricetin (DMY) as an NF-κB inhibitor or an IKK-β inhibitor for the treatment of arthritis, cancer, autoimmune conditions and other disease is provided. A pharmaceutical composition comprising DMY is also provided.
[Detail]
It introduces new technology to convert color image into grayscale image with high contrast for publishing, printing or medical imaging. In the conventional method, only luminance is used for the conversion of color images to grayscale images. Visual contrasts that are visible in color images become.....
[Detail]
This invention is to provide two new polyprenylated benzoylphloroglucinol derivatives, garciesculentones A and C (compounds 1 and 2), which exhibited cytotoxicity and antimigration effect against the tested human cancer cell lines and have potential to be developed as anticancer drugs.
[Detail]
